Ombudsman Jesus Crispin Remulla defended the decision to withdraw and review the Pharmally cases filed at the Sandiganbayan, saying the initial pleadings appeared flawed.
He noted that some cases, including one with no alleged government damage, could confuse the court’s jurisdiction.
The reconfiguration follows suspicions over the hurried filing of the P4-billion graft cases before his appointment.
The cases involve the anomalous purchase of medical equipment from Pharmally during the COVID-19 pandemic, despite the company having a small start-up capital.
A Senate probe later revealed that the government-purchased equipment was substandard, prompting scrutiny of the contracts.
Source: PhilNews24 | November 23, 2025
Latest from Politics
House Majority Leader Ferdinand Alexander Marcos has filed House Resolution No. 905, urging banks and financial
Former president and Pampanga Rep. Gloria Macapagal-Arroyo denied reports that she is seeking the ouster of
The government has expanded its value-added tax (VAT) exemption to more than 2,263 medicines, with cancer
Health Secretary Teodoro Herbosa said complaints filed against him over alleged expired medicines and vaccines are
The Senate has approved on third and final reading Senate Bill No. 1629, or the Multi-Faith
